Skip to content

Sight Sciences, Inc. SGHT Surgical Glaucoma — Cost of Goods Sold

Other segment segments

Dry Eye
$378K+226%

Similar metrics at other companies

Apyx Medical Corporation logo
APYXSurgical Aesthetics — Cost of Goods Sold
$3.26M+40.5%
Glaukos logo
GKOSDevelopment And Commercialization Of Ophthalmic Therapies — Cost of Goods Sold
$33.34M+37.1%
IAR
IARTSpecialty Surgery — Cost of goods sold
$110.48M+0.6%
Hyperfine, Inc. logo
HYPRProduct — Cost of Goods Sold
$1.65M+67.1%
Outset Medical, Inc. logo
OMProduct — Cost of Goods Sold
$8.83M-19.7%
Neuronetics logo
STIMMedical Device — Cost of Goods Sold
$2.86M-9.3%

Other financials

Income statement

See full
Revenue$19.7M+12.5%
Gross profit$17.0M+12.5%
Operating income-$12.4M+10.4%
Net income-$13.0M+8.3%
EPS (diluted)-$0.24+14.3%

Balance sheet

See full
Cash & equivalents$85.0M-21.9%
Total debt$40.9M+1.1%
Total equity$53.9M-30.6%
Total assets$109.7M-15.4%

Cash flow

See full
Operating cash flow-$7.0M+39.4%
CapEx$60.0K
Free cash flow-$7.1M+38.9%

Valuation

See full
Market cap$294.9M+35.0%
Enterprise value$250.83M+59.0%
P/S3.7×+0.8×

Profitability

See full
Gross margin86.2%+0.5pp
Operating margin-44.8%-10.2pp
Net margin-46.8%-9.6pp
FCF margin-31.9%+0.2pp

Returns & leverage

See full
Return on equity-56.6%+4.3pp
Debt / equity0.8×+0.2×
Current ratio5.9×-4.6×

Where this comes from

Reported directly by Sight Sciences, Inc. in its filing.

Tagged under the XBRL concept us-gaap:CostOfGoodsAndServicesSold.

The official record: Sight Sciences, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold?
Sight Sciences, Inc. (SGHT) reported surgical glaucoma — cost of goods sold of $2.34M in Q1 2026.
How has Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold changed year-over-year?
Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold increased by 1.9% year-over-year, from $2.3M to $2.34M.
What is the long-term trend for Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold?
Over 4 years (2021 to 2025), Sight Sciences, Inc.'s surgical glaucoma — cost of goods sold has grown at a 11.6% compound annual growth rate (CAGR), from $6.47M to $10.03M.
What does surgical glaucoma — cost of goods sold mean?
This metric captures the direct costs incurred to manufacture and deliver the surgical glaucoma products and services, including materials, labor, and overhead directly attributable to production. Monitoring this figure is essential for assessing the direct production efficiency and the impact of supply chain costs on the segment's profitability. Changes in this metric relative to revenue can indicate shifts in manufacturing scale or input cost inflation.